REGN vs VRTX
REGN 与 VRTX 的估值与基本面并排对比(公开数据)。
关键统计
| 指标 | REGNREGENERON PHARMACEUTICALS, INC. | VRTXVERTEX PHARMACEUTICALS INC / MA |
|---|---|---|
| 市值 | — | $125.77B |
| 市盈率(TTM) | 19.4 | 28.9 |
| 市净率 | — | 6.21 |
| 市销率 | — | 10.5x |
| 营收 | $15.53B(TTM) | $12.59B(TTM) |
| 营收同比增长 | 1.0% | 8.9% |
| 净利润 | $4.33B(TTM) | $4.41B(TTM) |
| 净利同比增长 | 2.1% | 838.1% |
| 每股收益(稀释) | $40.41(TTM) | $17.17(TTM) |
| 息税前利润率 | 24.9% | 34.8% |
| 净资产收益率 | 14.2% | 19.5% |
| 投入资本回报率 | 9.4% | 25.0% |
| 一年总回报 | +40.0% | +32.1% |
数据来自 SEC 文件 · 仅供参考 · 非投资建议
1 万美元的成长:REGN vs VRTX
| 指标 | REGN | VRTX |
|---|---|---|
| 期末价值 | $18.5K | $54.3K |
| 总回报 | +85.1% | +443.3% |
| 年化收益 (CAGR) | +6.1% | +17.8% |
| 波动率 | 32.2% | 32.9% |
| 夏普比率 | 0.23 | 0.55 |
| 索提诺比率 | 0.33 | 0.80 |
| 最大回撤 | -59.7% | -41.6% |
基于 2600 个共同交易日,2016-04-06 → 2026-08-07 · 无风险利率 3.87%(当前短端国债,全程恒定)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
相关对比
数据延迟 · 公开数据 · 仅供参考 · 非投资建议(本页不评判孰优孰劣)